Table 1.
Lean mass status |
P value | |||
---|---|---|---|---|
Overall |
Low |
Normal |
||
N = 599 | N = 285 | N = 314 | ||
Age, years | 51.3 ± 14.1 | 54.5 ± 13.3 | 48.5 ± 14.2 | <.001 |
Age category | ||||
18-40 years | 143 (23.9) | 45 (15.8) | 98 (31.2) | <.001 |
40-60 years | 268 (44.7) | 129 (45.3) | 139 (44.3) | |
60-70 years | 131 (21.9) | 78 (27.4) | 53 (16.9) | |
>70 years | 57 (9.5) | 33 (11.6) | 24 (7.6) | |
Female sex | 470 (78.5) | 251 (88.1) | 219 (69.8) | <.001 |
Hispanic race | 4 (0.7) | 1 (0.4) | 3 (1.0) | .30 |
Ethnicity | .12 | |||
American Indian | 2 (0.3) | 1 (0.4) | 1 (0.3) | |
Black | 12 (2.0) | 2 (0.7) | 10 (3.2) | |
White | 581 (97.0) | 279 (97.9) | 302 (96.2) | |
Other | 4 (0.7) | 3 (1.1) | 1 (0.3) | |
Insurance | .74 | |||
Medicare | 133 (22.2) | 67 (23.2) | 66 (21.0) | |
Medicaid/State assistance | 51 (8.5) | 23 (8.1) | 28 (8.9) | |
Commercial/other | 415 (69.3) | 195 (68.7) | 220 (70.1) | |
Smoking status | .48 | |||
Current | 38 (6.3) | 15 (5.3) | 23 (7.3) | |
Former | 179 (29.9) | 81 (28.4) | 98 (31.2) | |
Never | 374 (62.4) | 184 (64.6) | 190 (60.5) | |
Unknown | 8 (1.3) | 5 (1.8) | 3 (1.0) | |
Comorbiditiesa | ||||
Anxiety | 158 (26.4) | 73 (25.6) | 85 (27.1) | .62 |
COPD | 7 (1.2) | 7 (2.5) | 0 | .005 |
CAD | 40 (6.7) | 14 (4.9) | 26 (8.3) | .09 |
Depression | 179 (29.9) | 84 (29.5) | 95 (30.3) | .76 |
Diabetes | 102 (17.0) | 50 (17.5) | 52 (16.6) | .80 |
High cholesterol | 178 (29.7) | 89 (31.2) | 89 (28.3) | .50 |
Osteoarthritis | 115 (19.2) | 43 (15.1) | 72 (22.9) | .01 |
Sleep apnea | 210 (35.1) | 85 (29.8) | 125 (39.8) | .007 |
Cerebrovascular disease | 10 (1.7) | 7 (2.5) | 3 (1.0) | .16 |
NAFLD | 33 (5.6) | 17 (6.0) | 16 (5.2) | .67 |
Values represented are means ± standard deviation, counts (column percents). All participants were classified as having body-fat defined obesity. Sarcopenia was defined using the FNIH-definition of ALM (<26 kg in men; <16 kg in women).
Abbreviations: ALM, appendicular lean mass; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; NAFLD, non-alcoholic fatty liver disease.
Eight participants did not have any medical problems documented in the problem list.